Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | revenue | rating |
---|---|---|---|---|---|---|---|
Annexon, Inc. | $4.80 | $523.15 M | -3.93 | 70 | $0 | ||
Beam Therapeutics Inc. | $23.48 | $1.91 B | -14.51 | 346 | $377.71 M | ||
Blueprint Medicines Corporation | $109.03 | $6.47 B | -21.48 | 645 | $249.38 M | ||
Caribou Biosciences, Inc. | $1.60 | $176.12 M | -1.41 | 158 | $34.48 M | ||
Editas Medicine, Inc. | $4.66 | $435.86 M | -2.56 | 265 | $78.12 M | ||
G1 Therapeutics, Inc. | $2.57 | $157.37 M | -5.02 | 100 | $82.51 M | ||
Heron Therapeutics, Inc. | $2.77 | $542.35 M | -6.55 | 126 | $127.04 M | ||
Icosavax, Inc. | $15.31 | $769.04 M | -6.96 | 60 | $582,000 | ||
Century Therapeutics, Inc. | $2.27 | $244.54 M | -1.32 | 152 | $2.24 M | ||
iTeos Therapeutics, Inc. | $14.78 | $603.25 M | -4.42 | 157 | $12.60 M | ||
aTyr Pharma, Inc. | $1.90 | $131.12 M | -2.16 | 56 | $353,000 | ||
Mirati Therapeutics, Inc. | $58.70 | $4.12 B | -4.82 | 587 | $12.44 M | ||
Intellia Therapeutics, Inc. | $22.95 | $2.19 B | -4.23 | 526 | $36.28 M | ||
Prime Medicine, Inc. | $5.34 | $788.60 M | -3.01 | 234 | $0 | ||
Relay Therapeutics, Inc. | $6.27 | $1.05 B | -3 | 309 | $25.55 M | ||
Sana Biotechnology, Inc. | $5.22 | $1.55 B | -4.59 | 328 | $0 | ||
Sangamo Therapeutics, Inc. | $0.32 | $119.17 M | -0.31 | 405 | $176.23 M | ||
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 | ||
VectivBio Holding AG | $16.87 | $1.06 B | -8.03 | 0 | $27.34 M | ||
Verve Therapeutics, Inc. | $5.14 | $409.24 M | -1.82 | 255 | $11.76 M |